JOHNSON JOHN 4
4 · Axogen, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Axogen (AXGN) Director John Johnson Receives 4,392 RSUs
What Happened
John Johnson, a director of Axogen, Inc., was granted 4,392 restricted stock units (RSUs) on June 24, 2026. The RSUs are reported at $0.00 per share on the Form 4 (derivative award) and were valued at $185,000 on the grant date. The award vests in one year on June 24, 2027. This is a compensation grant (an acquisition via award), not an open-market purchase.
Key Details
- Transaction type: Award/Grant (code A) — 4,392 RSUs acquired, $0.00 price per unit on the Form 4.
- Grant valuation: The number of RSUs reflects a $185,000 grant value as of the grant date (footnote F2).
- Vesting: The RSUs vest on June 24, 2027 (one-year cliff vest).
- What the RSUs mean: Each RSU is a contingent right to receive one share of Axogen common stock upon vesting (footnote F1).
- Filing timeliness: Form 4 filed June 26, 2026 for a June 24, 2026 grant — appears to be timely (within the two-business-day window).
- Shares owned after transaction: Not specified in the provided filing details.
Context
RSU grants to directors are common as board compensation and represent future potential ownership if and when they vest and convert to shares. Because this is a compensation award rather than an open-market purchase or sale, it should be viewed as part of routine director pay rather than a direct signal of the director buying or selling stock today.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-06-24+4,392→ 4,392 total→ Common Stock (4,392 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F2]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.